ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in New Haven, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Adenocarcinoma
Hypersensitivity
Recurrence
Breast Cancer

Prostate Cancer trials near New Haven, CT, USA:

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (DASL-HiCaP)

androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...

Active, not recruiting
Prostate Cancer
Drug: Placebo oral tablet
Drug: Luteinizing Hormone-Releasing Hormone Analog

Phase 3

University of Sydney

Commack, New York, United States and 92 other locations

pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007

Phase 1

Janux Therapeutics

New Haven, Connecticut, United States and 15 other locations

Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA val...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110 in Combination with Abiraterone

Phase 1

Arvinas
Arvinas

New Haven, Connecticut, United States and 17 other locations

Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...

Enrolling
Prostate Adenocarcinoma
Prostate Cancer
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Hawthorne, New York, United States and 37 other locations

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2

Novartis
Novartis

New Haven, Connecticut, United States and 22 other locations

is a safe and effective way to treat previously untreated metastatic prostate cancer, and to see whether the study treatment works ...

Active, not recruiting
Metastatic Prostate Cancer
Drug: Abiraterone
Drug: Prednisone

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Commack, New York, United States and 7 other locations

The goal of this clinical trial is to measure the toxicity and effectiveness of the following treatments for cFIR/cgUIR prostate cancer...

Enrolling
Prostate Cancer
Radiation: SBRT standard of care radiotherapy treatment
Drug: Relugolix 120 MG [Orgovyx]

Phase 2

Yale University
Yale University

New Haven, Connecticut, United States and 1 other location

Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...

Enrolling
Prostate Cancer
Drug: Abiraterone
Drug: Enzalutamide

Phase 1

Amgen
Amgen

New Haven, Connecticut, United States and 54 other locations

with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials....

Enrolling
Prostate Cancer
Drug: AAA617

Phase 4

Novartis
Novartis

Hartford, Connecticut, United States and 53 other locations

This research study is comparing the use of a new form of hormonal therapy used with radiation as a possible treatment for intermediate risk prostate...

Active, not recruiting
Prostate Cancer
Radiation: Radiation Therapy
Drug: Darolutamide

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Stamford, Connecticut, United States and 10 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems